Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 10, 2012, Pages 2461-2470

  Rosado, Eugenio ^a   Rodríguez Vilarrupla, Aina ^a   Gracia Sancho, Jorge ^a   Monclús, Montserrat ^a   Bosch, Jaume ^a   García Pagán, Joan Carles ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cyclooxygenase; Endothelium; Nitric oxide; Portal hypertension; Superoxide

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; INDOMETACIN; MEMBRANE PROTEIN; NITRIC OXIDE; PTGS1 PROTEIN, RAT; SUPEROXIDE DISMUTASE; THROMBOXANE SYNTHASE; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; BIOAVAILABILITY; CYTOLOGY; DRUG ANTAGONISM; GENETICS; LIVER; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; RAT; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ARACHIDONIC ACID; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE 1; HEPATOCYTES; INDOMETHACIN; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; THROMBOXANE-A SYNTHASE; VASOCONSTRICTOR AGENTS;

RATTUS;

EID: 84866751112     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01563.x     Document Type: Article

References (35)

1. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000; 32: 141-56.
2. Groszmann RJ, Abraldes JG. Portal hypertension: from bedside to bench. J Clin Gastroenterol. 2005; 39: S125-30.
3. Graupera M, Garcia-Pagan JC, Abraldes JG, et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology. 2003; 37: 172-81.
4. Graupera M, Garcia-Pagan JC, Pares M, et al. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol. 2003; 39: 515-21.
5. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology. 2002; 35: 478-91.
6. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol. 2003; 284: G567-74.
7. Graupera M, March S, Engel P, et al. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am J Physiol Gastrointest Liver Physiol. 2005; 288: G763-70.
8. Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, et al. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. J Hepatol. 2007; 47: 220-7.
9. Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, et al. Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology. 2008; 47: 1248-56.
10. Van de Casteele M, Van Pelt JF, Nevens F, et al. Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: a comparison of two portal hypertensive rat models with healthy controls. Comp Hepatol. 2003; 2: 2.
11. Laleman W, Van Landeghem L, Van der Elst I, et al. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology. 2007; 132: 709-19.
12. Mollace V, Muscoli C, Masini E, et al. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev. 2005; 57: 217-52.
13. Upmacis RK, Deeb RS, Hajjar DP. Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat. 2006; 80: 1-14.
14. Goodwin DC, Landino LM, Marnett LJ. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J. 1999; 13: 1121-36.
15. Davidge ST, Baker PN, Laughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 1995; 77: 274-83.
16. Miyamoto A, Hashiguchi Y, Obi T, et al. Ibuprofen or ozagrel increases NO release and l-nitro arginine induces TXA(2) release from cultured porcine basilar arterial endothelial cells. Vascul Pharmacol. 2007; 46: 85-90.
17. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 1993; 90: 7240-4.
18. Davidge ST, Pitt BR, McLaughlin MK, et al. Biphasic stimulation of prostacyclin by endogenous nitric oxide (NO) in endothelial cells transfected with inducible NO synthase. Gen Pharmacol. 1999; 33: 383-7.
19. Ashton AW, Ware JA. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. Circ Res 2004; 95: 372-9.
20. DeLeve LD, Wang X, Hu L, et al. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am J Physiol Gastrointest Liver Physiol. 2004; 287: G757-63.
21. Gracia-Sancho J, Laviña B, Rodriguez-Vilarrupla A, et al. Evidence against NADPH oxidase modulating hepatic vascular tone in cirrhosis. Gastroenterology. 2007; 133: 959-66.
22. Garcia-Caldero H, Rodriguez-Vilarrupla A, Gracia-Sancho J, et al. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. J Hepatol. 2010; 54: 660-5.
23. Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol. 2007; 46: 927-34.
24. Cuzzocrea S, Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int. 2007; 71: 290-7.
25. Liu CQ, Leung FP, Wong SL, et al. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Biochem Pharmacol. 2009; 78: 374-81.
26. Abraldes JG, Graupera M, Zafra C, et al. Simvastatin improves sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol. 2005; 42: 62-3.
27. de Sotomayor MA, Perez-Guerrero C, Herrrera MD, et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol. 2005; 146: 1130-8.
28. Onodera M, Morita I, Mano Y, Murota S. Differential effects of nitric oxide on the activity of prostaglandin endoperoxide H synthase-1 and -2 in vascular endothelial cells. Prostaglandins Leukot Essent Fatty Acids. 2000; 62: 161-7.
29. Clancy R, Varenika B, Huang W, et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol. 2000; 165: 1582-7.
30. Upmacis RK, Deeb RS, Hajjar DP. Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry. 1999; 38: 12505-13.
31. Takeuchi K, Watanabe H, Tran QK, et al. Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression. Cardiovasc Res. 2004; 62: 194-201.
32. Goodwin DC, Gunther MR, Hsi LC, et al. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J Biol Chem. 1998; 273: 8903-9.
33. Shimokawa T, Kulmacz RJ, DeWitt DL, Smith WL. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem. 1990; 265: 20073-6.
34. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci. 1997; 53: 576-82.
35. Vassalle C, Domenici C, Lubrano V, L'Abbate A. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res. 2003; 40: 491-9.